INTRODUCTION
knowledge of these proteins has facilitated analysis of molecular mechanisms of autophagy (1) . In response to starvation, most of the Atg proteins are localized at a perivacuolar punctate structure called the pre-autophagosomal structure (PAS) (6) . According to the prevailing model, a membrane structure, termed the isolation membrane, emerges from the PAS, sequesters a portion of cytoplasm, seals, and finally forms a double-membrane structure, termed the autophagosome.
Atg9, a six-transmembrane protein exposing both the N-and C-terminal domains to the cytoplasm, is essential for autophagosome formation both in yeast and mammals (7) (8) (9) (10) .
Recently, we showed that the majority of Atg9 However, it remains unclear how Atg9 vesicles function. In this study, we characterized Atg9 vesicles by immunopurification followed by mass spectrometric analysis, which identified
Trs85 and Ypt1 as proteins that reside on Atg9
vesicles. Trs85 is a component of the transport protein particle III (TRAPPIII) complex (12) .
TRAPP complexes are known to function as a GDP/GTP exchange factor (GEF) for Rab
GTPases, Ypt proteins in yeast, and also as vesicle-tethering complexes required for membrane trafficking between the endoplasmic reticulum (ER) and the Golgi apparatus (13) .
The Rab GTPase Ypt1 also functions in vesicle tethering (14) . Although both Trs85 and Ypt1
were reported to be localized to the PAS and involved in autophagy (12, 15, 16) , to date it is unclear how these proteins are localized to the PAS and in which step these proteins function during autophagosome formation. Here, we suggest that Atg9 vesicles transport Trs85 and Ypt1 toglucose) or in SD/CA medium (0.17% yeast nitrogen base without amino acids and ammonium sulfate, 0.5% ammonium sulfate, 0.5% casamino acids, and 2% glucose)
supplemented with appropriate amino acids.
Autophagy was induced by treatment with 0.2 !g/ml rapamycin (Sigma). Gene deletion, truncation, promoter replacement, and C-terminal protein tagging with GFP, HA, Myc, and TAP were performed as described previously (18) . The plasmids for expression of Atg9 and Atg9-6xFLAG, and cells expressing Atg9-2xGFP and Atg9-3xBAP were constructed as described previously (11). To construct strains expressing mRFP-Ape1, pPS128 and pPS129 were integrated into the genome after digestion with AflII and AvrII, respectively, as described previously (19) . To construct the strain expressing GFP-Ypt1 from the native promoter, a DNA fragment encoding yeGFP-YPT1 was integrated into the YPT1 locus by homologous recombination. In the resulting strain, yeGFP-Ypt1 is transcribed from its own promoter and terminated with the PGK1
terminator. The plasmid for expression of GFP-Atg8 was described previously (6) .
Antibodies against Vph1, Pgk1, Dpm1, Por1, and Pep12 were purchased from Invitrogen.
Antibodies against GFP and HA (3F-10) were purchased from Roche. Anti-Myc antibody (9E10) was purchased from BabCo. Anti-Sed5
antibody was a kind gift from Dr. Koji Yoda (The University of Tokyo, Japan). Polyclonal antibodies against Atg9 and Atg27 were described previously (7, 11 sorbitol, and 5 mM EDTA) including 0.5 mg/ml BSA and 50 mM NaCl. After centrifugation at 50,000 x g for 20 min at 4°C, the supernatants were incubated with anti-FLAG antibody-bound Dynabeads® Protein G (Dynal) for 3 hr at 4°C.
The beads were collected using a magnetic stand and washed three times with HSE buffer including 0.5 mg/ml BSA and 250 mM NaCl. In the two-step purification, elution was performed using 2 mg/ml 3xFLAG peptide (Sigma), and the eluate was incubated with Dynabeads® MyOne™ Streptavidin C1 (Dynal) for 20 min at 4°C. First, the beads were incubated with 0.5% Triton X-100 for 5 min on ice and then incubated at 65°C for 10 min with SDS-PAGE buffer. After centrifugation at 15,000 x g, the supernatants were solubilized with 0.5% Triton Table S2 . molecules) (11), we expected that each vesicle in these cells will contain both FLAG-tagged and BAP-tagged Atg9, and therefore we utilized these tagged proteins for two-step purification.
Two-hybrid assays -

Cells expressing non-tagged Atg9 instead of
Atg9-6xFLAG were used as a negative control.
The two-step purification was performed as illustrated in Figure 1A . At the first step, Atg9
vesicles were immunoisolated using anti-FLAG beads and eluted with 3xFLAG peptide (Fig. 1A and 1B, Step 1). By this step, Atg9-6xFLAG
was isolated specifically, in contrast to the negative control sample (E1 fractions in Fig. 1B ).
Electron microscopy of the E1 fractions revealed vesicular structures with a diameter of 30!50 nm ( (Fig. 1B) . The proteins in E2 and E3 fractions were visualized using SYPRO Ruby (Fig. 1D ).
Atg9 vesicle-specific bands, i.e., those not present in the negative control lanes, were cut out and subjected to mass spectrometry by three (27) . As shown in Figure 1E , Trs85 and Ypt1 were coprecipitated with Atg9-6xFLAG in both growing and rapamycin-treated cells. We performed an additional experiment using atg11" atg17" cells, in which the PAS is not formed and autophagosome formation is completely blocked.
Trs85 and Ypt1 were coprecipitated even in atg11" atg17" cells (Fig. 1E) . vesicles bound to anti-FLAG beads were treated with 0.5% Triton X-100 on ice ( Fig. 2A, TX) , and then treated with 1.6% SDS at 65°C to recover all proteins bound to the beads ( Fig. 2A,   SB) . By the treatment with Triton X-100, Atg9-6xFLAG was not efficiently released from the beads ( Fig. 2A) , indicating that the large majority of Atg9-6xFLAG was directly associated with anti-FLAG beads. Likewise, beads, but not with Trs65-bound beads (Fig. 2D ).
Although both Trs85-bound beads and
Trs65-bound beads contained common subunits of TRAPP complexes ( Fig. S1B and S1C ), the Atg9 vesicles were associated only with Trs85-bound beads. Therefore, these results suggested that Atg9 vesicles bound directly to
Trs85, but not to other TRAPP subunits (Fig.   2E ). Trs85-2xGFP and RFP-Ape1, which is the most widely studied cargo of selective autophagy and is frequently used as a PAS marker (1). We examined the localization of these proteins under growing and rapamycin-treated conditions.
The PAS localization of Trs85 is dependent on Atg9
Fluorescence microscopy revealed that only a minor, but significant portion of Trs85-2xGFP does indeed colocalize with RFP-Ape1 in rapamycin-treated cells (Fig. 3A , top, 31% of Ape1 puncta was colocalized with Trs85).
However, the colocalization of Trs85-2xGFP
with RFP-Ape1 was significantly diminished in atg9" cells (Fig. 3A , middle, 6% colocalized).
Under growing conditions, the PAS localization of Trs85 was similarly reduced in atg9" cells ( (Fig. 3C) . On the contrary, the PAS localization of Trs85 was not blocked in the absence of Atg14 (Fig. S3 ).
Similar to Atg14-2xGFP, GFP-Atg8 was not localized to the PAS under growing conditions in trs85" cells ( (Fig. S2D) . vesicles is dependent on Trs85. We carried out a co-immunoprecipitation assay using wild-type and trs85" cells expressing Atg9-6xFLAG. The amount of coprecipitated Ypt1 was decreased in trs85" cells relative to wild-type cells (Fig. 4B) .
Ypt1 is localized on Atg9 vesicles and to
From these findings, we conclude that Ypt1 is associated onto the Atg9 vesicles with the aid of Trs85 (and the TRAPPIII complex), and thereby Atg9 vesicles recruit Ypt1 to the PAS (Fig. 4C) . Trs85 is dependent on Atg9, but not vice versa ( Fig. 3A and B) . As Trs85 is the sole specific subunit of the TRAPPIII complex, it is likely that Trs85 directs the TRAPPIII complex to the PAS via its interaction with Atg9 (Fig. 4C ).
DISCUSSION
Ypt1 is also localized to the PAS in an Atg9-and Trs85-dependent manner. Ypt proteins, or Rab GTPases, are prenylated and attached to membranes; this membrane association is assumed to be facilitated by GEFs, such as TRAPP complexes, although the detailed mechanism is controversial (14, 30, 31) . It seems likely that the TRAPPIII complex recruits Ypt1 onto Atg9 vesicles, resulting in the PAS localization of Ypt1 (Fig. 4C) . Small amounts of Ypt1 are present on Atg9 vesicles even in trs85" cells ( Fig. 4B) , i.e., Ypt1 binds to the Atg9 vesicles to some extent regardless of the aid of the TRAPPIII complex. In proteomic analyses of (Table S2) , both of which are Ypt1-interacting proteins (32, 33) . These proteins may also be recruited to the PAS as components of Atg9 vesicles and regulate the activity of Ypt1. Our analyses also detected two proteins that are involved in phosphoinositide metabolism, Mss4
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